Skip to content

REPEAT INDUCTION VERSUS EXPECTANT MANAGEMENT AFTER FAILED PRIMARY LABOR INDUCTION AT TERM: A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL.

REPEAT INDUCTION VERSUS EXPECTANT MANAGEMENT AFTER FAILED PRIMARY LABOR INDUCTION AT TERM: A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201805002872322
Enrollment
86
Registered
2017-12-15
Start date
2017-12-18
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth FAILED PRIMARY LABOR INDUCTION

Interventions

REPEAT LABOR INDUCTION

Sponsors

RESEARCH & PROGRAMS: KENYATTA NATIONAL HOSPITAL
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The participants to be included will be mothers for induction of labor with: 1.Singleton, live gestation in cephalic presentation 2.Gestation at or beyond 37 weeks 0 days (37 0/7) 3.Post-term pregnancy 4.Bishop score <6 at failed primary labor induction diagnosis 5.Reactive fetal heart rate pattern 6.Intact membranes 7.Oligohydramnios 8.Hypertensive disorders (preeclampsia without severe features and pregnancy induced hypertension) 9.Diabetes mellitus requiring insulin 10.Maternal cardiac disease: mild cardiac disorders 11.Fetal growth restriction without evidence of fetal compromise on Doppler U/S 12.Elective induction 13.Willing to participate and give a signed informed consent

Exclusion criteria

Exclusion criteria: The participants to be excluded from primary and repeat IOL will be those who have: 1)Contraindications to induction Absolute: more than 2 previous uterine scar, previous myomectomy, malposition Relative: malpresentation, non reactivenonstress test, para>3, severe maternal heart disease, severe maternal hypertension, polyhydramnios 2)Contraindications to vaginal delivery e.g. contracted pelvis, type 4 placenta praevia, umbilical cord prolapse, active genital herpes infection, invasive cervical cancer 3)Multiple gestation 4)Estimated fetal weight >4000 or <2000 grams 5)Hypersensitivity to prostaglandins 6)Severe asthma

Design outcomes

Secondary

MeasureTime frame
1)Time from induction to second stage (induction-delivery interval);2)Time from induction to decision to perform CS;3)Final mode of delivery: vaginal vs caesarean delivery;4)Adverse maternal outcome defined as or including maternal nausea, vomiting, diarrhea, postpartum haemorrhage, uterine hyperstimulation with FHR changes, uterine rupture, instrumental vaginal delivery, intensive care unit admission, chorioamnionitis, duration of hospital stay, maternal death;5)Early neonatal morbidity defined as or including meconium-stained liquor, Apgar score less than seven at five minutes, NICU admission for more than 48 hours, neonatal encephalopathy, perinatal death

Primary

MeasureTime frame
1) Time from induction to active phase of labor: entry into active phase of labor within the designated time. This was chosen as a primary outcome in line with literature review that failed IOL should be defined as the inability to achieve active phase of labor. In this instance, final outcome of pregnancy (mode of delivery) which is associated with confounders is not considered.

Countries

Kenya

Contacts

Public ContactSubaha Mohamed

MMED OBGYN Resident in University of Nairobi

sabahhania@gmail.com+254720255153

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026